IP Library Granted Patent US 11,479,756
Granted Patent B2
US 11,479,756 · App. 17/149,463 · Granted Oct 25, 2022

Ketoreductase polypeptides for the reduction of acetophenones

Inventors: Jack Liang (South San Francisco, CA); Stephane J. Jenne (Foster City, CA); Emily Mundorff (Garden City, NY); Charlene Ching (San Jose, CA); John M. Gruber (Mountain View, CA); Anke Krebber (Palo Alto, CA); Gjalt W. Huisman (Redwood City, CA)
Assignee: Codexis, Inc.
C12N9/0006C12P7/22C12Y101/01184C12Y101/01Y02E50/10Y02P20/52
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,479,756
App. No.
17/149,463
Granted
Oct 25, 2022
Kind
B2
Abstract

The present disclosure provides engineered ketoreductase enzymes having improved properties as compared to a naturally occurring wild-type ketoreductase enzyme. Also provided are polynucleotides encoding the engineered ketoreductase enzymes, host cells capable of expressing the engineered ketoreductase enzymes, and methods of using the engineered ketoreductase enzymes to synthesize a variety of chiral compounds.

Claims (13)

1. An engineered polynucleotide encoding a recombinant ketoreductase polypeptide capable of stereoselectively reducing acetophenone to (S)-1-phenethanol, wherein said polypeptide comprises an amino acid sequence that is at least 95% identical to the reference sequence of SEQ ID NO: 119, wherein said ketoreductase polypeptide is capable of reducing acetophenone to (S)-1-phenethanol at a rate greater than the rate capable by the ketoreductase polypeptide having the sequence of SEQ ID NO: 6.

2. The engineered polynucleotide of claim 1 , wherein said engineered polynucleotide encodes a recombinant ketoreductase polypeptide capable of stereoselectively reducing the substrate 2′,6′-dichloro-3′-fluoroacetophenone to the product (S)-1-(2,6-dichloro-3-fluorophenyl) ethanol with a percent stereomeric excess of at least 99%.

3. The engineered polynucleotide of claim 1 , wherein said engineered polynucleotide encodes a recombinant ketoreductase polypeptide capable of reducing the substrate 2′,6′-dichloro-3′-fluoroacetophenone to the product (S)-1-(2,6-dichloro-3-fluorophenyl) ethanol at a rate that is at least 450% greater than the rate capable by the ketoreductase polypeptide having the sequence of SEQ ID NO:6.

4. The engineered polynucleotide of claim 1 , wherein said engineered polynucleotide encodes a recombinant ketoreductase polypeptide capable of reducing the substrate 2′,6′-dichloro-3′-fluoroacetophenone to the product (S)-1-(2,6-dichloro-3-fluorophenyl) ethanol at a rate that is at least 1500% greater than the rate capable by the ketoreductase polypeptide having the sequence of SEQ ID NO:6.

5. The engineered polynucleotide of claim 1 , wherein said engineered polynucleotide encodes a recombinant ketoreductase polypeptide comprising a proline at the position corresponding to position 190 of SEQ ID NO:119.

6. An expression vector comprising the engineered polynucleotide of claim 1 .

7. The vector of claim 6 , wherein said polynucleotide is operably linked to regulatory sequences suitable for expression of said polynucleotide in a suitable host cell.

8. The vector of claim 7 , wherein said host cell is a prokaryotic or eukaryotic cell.

9. The vector of claim 8 , wherein said host cell is a prokaryotic cell.

10. The vector of claim 9 , wherein said host cell is E. coli.

11. A host cell comprising the vector of claim 6 .

12. A method for producing at least one recombinant ketoreductase polypeptide comprising culturing the host cell of claim 11 under conditions such that a recombinant ketoreductase polypeptide is produced.

13. The method of claim 12 , further comprising the step of recovering said at least one recombinant ketoreductase polypeptide.

Assignments (1)
SECURITY INTEREST Recorded Feb 15, 2024
From: CODEXIS, INC.
To: INNOVATUS LIFE SCIENCES LENDING FUND I, LP, AS COLLATERAL AGENT
Reel/Frame 066600/0650 →
Continuity (11)
Continuation 16253972 · Jan 22, 2019
Continuation 16126761 · Sep 10, 2018
Continuation 15915927 · Mar 8, 2018
Continuation 15840381 · Dec 13, 2017
Continuation 15353165 · Nov 16, 2016
Division 14501416 · Sep 30, 2014
Continuation 13970284 · Aug 19, 2013
Continuation 13682600 · Nov 20, 2012
Division 12210195 · Sep 13, 2008
Provisional Application 60972058 · Sep 13, 2007
Related Publication 20210139861A1 · May 13, 2021